World Clinical Drug
|
2022, 43(5): 609-614
• Article •
Durvalumab combined with radiotherapy for treatment of rare spinal cord metastasis of triple-negative breast cancer
Full
Huimi YU1, Xueya MIN2, Shiqi QIAO2, Zhen GAO1, Xuemin DI1, Hongtao ZHANG1, *
Affiliations
- 1.Department of Oncology, Hebei Provincial People's Hospital, Shijiazhuang 050051, Hebei Province, China
- 2.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
Published: 2022-05-10
doi: 10.13683/j.wph.2022.05.020
Outline
spinal cord intramedullary metastasis
/
triple-negative breast cancer
/
meningeal metastasis
/
durvalumab
/
PD-L1 inhibitor
/
radiotherapy
于慧敏, 闵学雅, 乔诗淇, 高贞, 底学敏, 张宏涛.
1例度伐利尤单抗联合放疗治疗三阴性乳腺癌脊髓转移的病例分析.
世界临床药物,
2022
, 43
(5)
: 609
-614
.
DOI: 10.13683/j.wph.2022.05.020
Huimi YU, Xueya MIN, Shiqi QIAO, Zhen GAO, Xuemin DI, Hongtao ZHANG.
Durvalumab combined with radiotherapy for treatment of rare spinal cord metastasis of triple-negative breast cancer[J].
World Clinical Drug,
2022
, 43
(5)
: 609
-614
.
DOI: 10.13683/j.wph.2022.05.020
Year 2022 volume 43 Issue 5
9
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.05.020
- Receive Date:2021-10-15
- Online Date:2026-11-19
- Published:2022-05-10